The strategy likely will not be pursued, however studies of PARP inhibitors plus immune checkpoint inhibitors are already in advanced stages. Read more
Analysis of worldwide epidemiologic patterns may help governments and medical institutions formulate targeted strategies for addressing mesothelioma. Read more